Decline in Quantitative Serum HBsAg Level during Consolidation Therapy Following HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir

被引：0
|
作者：
Su, Wen-Pang [1 ]
Peng, Cheng-Yuan [1 ]
Lai, Hsueh-Chou [1 ]
Lin, Chia-Hsin [1 ]
Chuang, Po-Heng [1 ]
Chen, Sheng-Hung [1 ]
机构：
[1] China Med Univ Hosp, Taichung, Taiwan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1875
引用
收藏
页码：1102A / 1103A
页数：2
相关论文
共 50 条
  • [1] PREDICTION OF HBsAg KINETICS AND HBEAG LOSS DURING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kim, Hwi Young
    Jang, Tae Soo
    Lee, Joo Ho
    Lee, Hye Ah
    Kwon, Hee-Dae
    HEPATOLOGY, 2020, 72 : 518A - 518A
  • [2] ASSOCIATION BETWEEN GENOTYPE AND BASELINE HBsAg LEVELS AND THE HBsAg LEVELS AT HBeAg SEROCLEARANCE IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR
    Peng, C. -Y.
    Lai, H. -C.
    Su, W. -P.
    Lin, C. -H.
    Chuang, P. -H.
    Chen, S. -H.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S430 - S430
  • [3] Association between Genotype and the HBsAg Levels at HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir or Peginterferon Alfa-2a
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    HEPATOLOGY, 2014, 60 : 1121A - 1121A
  • [4] HBsAg loss in HBeAg positive and HBeAg negative patients with chronic HBV treated with Entecavir
    Sungur, Murvet
    Tuzcuoglu, Isil
    Acilar, Kemal
    Gokmen, Tulay
    Kurt, Kamile
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 649 - 649
  • [5] Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B
    Pfefferkorn, Maria
    Schott, Tina
    Boehm, Stephan
    Deichsel, Danilo
    Felkel, Christin
    Gerlich, Wolfram H.
    Glebe, Dieter
    Wat, Cynthia
    Pavlovic, Vedran
    Heyne, Renate
    Berg, Thomas
    van Boemmel, Florian
    JOURNAL OF HEPATOLOGY, 2021, 74 (02) : 283 - 292
  • [6] CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA
    Brouwer, W. P.
    Sonneveld, M. J.
    Xie, Q.
    Zhang, N.
    Zeuzem, S.
    Tabak, F.
    Zhang, Q.
    Simon, K.
    Akarca, U. S.
    Streinu-Cercel, A.
    Hansen, B.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S572 - S573
  • [7] OUTCOME OF 3-YEAR CONSOLIDATION THERAPY FOLLOWING HBEAG LOSS IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES
    Kim, J. K.
    Lee, K. S.
    Lee, J. I.
    Kang, A. Y.
    Chang, H. Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S592 - S592
  • [8] Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
    Gish, R. G.
    Chang, T. -T.
    Lai, C. -L.
    de Man, R.
    Gadano, A.
    Poordad, F.
    Yang, J.
    Brett-Smith, H.
    Tamez, R.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (01) : 16 - 22
  • [9] A QUANTITATIVE STUDY OF DYNAMIC CHANGE AND EARLY DECLINE IN HBEAG AND HBSAG LEVELS AS OUTCOME PREDICTORS DURING ANTIVIRAL THERAPY FOR HBEAG-POSITIVE CHRONIC HEPATITIS B
    Kwon, Jung Hyun
    Jong, Jeong Won
    Yoo, Sun Hong
    Song, Myeong Jun
    Park, Chung-Hwa
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Chung, Kyu Won
    HEPATOLOGY, 2010, 52 (04) : 540A - 540A
  • [10] EARLY HBEAG LOSS DURING LAMIVUDINE THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS WITH ACUTE EXACERBATION
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    HEPATOLOGY, 2009, 50 (04) : 515A - 515A
12345